about
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 PathwaysThe 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migrationCannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.Manganese superoxide dismutase: effect of the ala16val polymorphism on protein, activity, and mRNA levels in human breast cancer cell lines and stably transfected mouse embryonic fibroblasts.Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells.Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteinsHeat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells(--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.Identification of urushiols as the major active principle of the Siddha herbal medicine Semecarpus Lehyam: Anti-tumor agents for the treatment of breast cancerPromoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cellsAntineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studiesProtein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patientsLow-carbohydrate diets, dietary approaches to stop hypertension-style diets, and the risk of postmenopausal breast cancer.Convex clustering: an attractive alternative to hierarchical clustering.Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene.Acceleration of pro-caspase-3 maturation and cell migration inhibition in human breast cancer cells by phytoconstituents of Rheum emodi rhizome extractsThe Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer.A study of the potential anticancer activity of Mangifera zeylanica bark: Evaluation of cytotoxic and apoptotic effects of the hexane extract and bioassay-guided fractionation to identify phytochemical constituentsThe molecular genetics of breast cancer and targeted therapyAdvances in novel drug delivery strategies for breast cancer therapy.Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells.Different apoptotic effects of saxifragifolin C in human breast cancer cells.Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells.Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK.
P2860
Q27315022-C3801EE3-FAE6-4F29-98A5-AFB26042D9A4Q28535344-F02C8C88-2D16-4AC1-AE50-7F07203C78C0Q33564023-BB022A3A-4229-4FB4-8A96-660EC2401CB6Q33604153-436E29F9-144F-4B67-A66D-6BD94582E5CFQ33669183-DD6BB496-5EB9-443A-89F1-7EEE85D578F9Q33669490-6FD46DDD-B026-44FC-BD74-268B42A03FC5Q33831321-6A660CD1-BC2D-4BC4-9941-2D39857577DFQ33872756-851E5C51-26C3-404B-A4C9-0633DCD61BC2Q33966511-347CD318-E57C-4911-86F9-82BF1171BCA2Q34006827-4C36BBDB-3362-4BCA-BA0E-EAAA89CF466BQ34602854-09D7582F-4A4B-4FF6-B825-C43894851E23Q34635316-E6C1859B-2932-4031-AF34-54727B2B7AC4Q34998421-C71B7047-8E2A-4B1B-8555-A143717B3611Q35195581-3D819874-33D6-4EE9-8848-321D0F95703DQ35627859-78BF42F9-4C04-43E6-BFCB-673A85D72E22Q35697542-C77AF7C8-E256-473D-AE24-360ED1E6C415Q36051386-4C214D81-E8BC-48FF-8797-9887BB495F36Q36092019-34B1FFDE-602A-46DE-9B78-D258E7406BACQ36524847-D010805C-F2CD-47B0-B965-B10F04CAB396Q37290512-79B67350-A440-43BF-969F-051A96A5F1FCQ37777142-0EB3E400-F19B-461B-B06A-A4647B9C9F3AQ38989156-3EA34F34-3552-45F7-BBB7-F51BB33925E4Q39542346-E5AD4FB7-0934-4E29-8D36-A8A286DCCEC7Q39900183-278EEF25-F84B-4090-8696-4C3C573BCC9BQ39930598-1BDCE1F7-ABB4-4660-8EDD-E789A3384B3DQ40424228-74BCD834-CC15-4EBE-AED8-34FE1B02CA09Q40531854-0D817582-3723-4DDE-9468-837E3B96D7E1
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
How to target estrogen receptor-negative breast cancer?
@ast
How to target estrogen receptor-negative breast cancer?
@en
type
label
How to target estrogen receptor-negative breast cancer?
@ast
How to target estrogen receptor-negative breast cancer?
@en
prefLabel
How to target estrogen receptor-negative breast cancer?
@ast
How to target estrogen receptor-negative breast cancer?
@en
P2093
P356
P1476
How to target estrogen receptor-negative breast cancer?
@en
P2093
P304
P356
10.1677/ERC.0.0100261
P577
2003-06-01T00:00:00Z